Valeant Chairman Robert O’Leary
Executive Summary
Valeant Chairman Robert O'Leary died at the age of 62 following a long battle with cancer, company announces Aug. 14. Board elects GlaxoSmithKline Vice Chairman-Pharmaceuticals Robert Ingram, a member of Valeant's board since 2003, to serve as chairman. Ingram has also chaired OSI Pharmaceutical's board since 2003 (1"The Pink Sheet" Jan. 13, 2003, In Brief)...